Skip to content

13F-HR filed by DAFNA Capital Management LLC

DAFNA Capital Management LLC filed this 13F-HR for the quarter ended 2016-09-30, filed 2016-11-14, with 74 holding rows worth $143,580,000.

Accession
0001389933-16-000037
Filed
2016-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2016

A holdings report, 75 entries on the cover page, a total value of $143,580,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $143,580,000 with VALUE read as thousands by filing date, 13F file number 028-12327. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
VITAE PHARMACEUTICALS INC92847N103COM715,988$14,978,000thousands by filing date
CYNAPSUS THERAPEUTICS INC23257Y859COM PAR NO PAR230,201$9,256,000thousands by filing date
ATRICURE INC04963C209COM528,946$8,368,000thousands by filing date
NXSTAGE MEDICAL INC67072V103COMMON STOCK238,509$5,960,000thousands by filing date
Tandem Diabetes Care, Inc.875372104COM724,286$5,548,000thousands by filing date
ALDER BIOPHARMACEUTICALS INC014339105COM165,313$5,417,000thousands by filing date
LAKEFRONT BIOTHERAPEUTICS NV36315X101SPON ADR66,068$4,272,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock514,091$4,164,000thousands by filing date
AERIE PHARMACEUTICALS INC00771V108COM91,869$3,467,000thousands by filing date
LOXO ONCOLOGY INC548862101COM130,222$3,409,000thousands by filing date
DERMIRA INC24983L104COM98,800$3,341,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM64,008$3,241,000thousands by filing date
INSULET CORP COM45784P101Stock73,484$3,008,000thousands by filing date
TESARO INC881569107COM29,500$2,957,000thousands by filing date
ARDELYX INC039697107COM219,095$2,835,000thousands by filing date
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR90,142$2,777,000thousands by filing date
PROTAGONIST THERAPEUTICS74366E102COM123,804$2,616,000thousands by filing date
FOAMIX PHARMACEUTICALS LTDM46135105SHS278,067$2,575,000thousands by filing date
INSULET CORP45784PAD3NOTE 2.000% 6/12,250,000$2,481,000thousands by filing dateprincipal
APPLIED GENETIC TECHNOL CORP03820J100COM240,298$2,350,000thousands by filing date
Rocket Pharmaceuticals Inc45780V102SHS237,235$2,249,000thousands by filing date
AEGLEA BIOTHERAPEUTICS INC00773J103COM350,392$2,246,000thousands by filing date
CARA THERAPEUTICS INC140755109COM267,046$2,230,000thousands by filing date
OPHTHOTECH CORP683745103COM46,600$2,150,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW36,854$1,993,000thousands by filing date
IMMUNOMEDICS INC452907108COM566,796$1,842,000thousands by filing date
BIOSPECIFICS TECHNOLOGIES090931106COM39,704$1,813,000thousands by filing date
CYTOKINETICS INC23282W605COM NEW181,737$1,668,000thousands by filing date
DERMA SCIENCES INC249827502COM PAR $.01353,718$1,652,000thousands by filing date
SPECTRANETICS CORP84760C107COM65,496$1,643,000thousands by filing date
MACROGENICS INC556099109COM54,200$1,621,000thousands by filing date
UNIQURE NVN90064101SHS203,907$1,560,000thousands by filing date
PROTALIX BIOTHERAPEUTICS INC74365AAB7NOTE 4.500% 9/12,500,000$1,525,000thousands by filing dateprincipal
SYNERGY PHARMACEUTICALS DEL871639308COM NEW274,563$1,513,000thousands by filing date
ACHILLION PHARMACEUTICALS IN00448Q201COM186,500$1,511,000thousands by filing date
BIOTELEMETRY INC090672106COM80,000$1,486,000thousands by filing date
REGULUS THERAPEUTICS INC75915K101COM421,500$1,391,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK340,000$1,248,000thousands by filing date
WINDTREE THERAPEUTICS INC97382D105COM480,833$1,231,000thousands by filing date
EIGER BIOPHARMACEUTICALS INC28249U105COM90,000$1,205,000thousands by filing date
STEREOTAXIS INC85916J409COMMON STOCK1,372,862$1,194,000thousands by filing date
NOVADAQ TECHNOLOGIES INC COMMON66987G102COM101,841$1,178,000thousands by filing date
Johnson & Johnson478160104COM9,400$1,110,000thousands by filing date
ZOGENIX INC.98978L204Common Stock79,538$909,000thousands by filing date
EXACTECH INC30064E109COM31,636$855,000thousands by filing date
SCYNEXIS INC COM NEW811292101Common Stock213,250$825,000thousands by filing date
INOTEK PHARMACEUTICALS CORP45780VAB8NOTE 5.750% 8/0600,000$794,000thousands by filing dateprincipal
ESSA PHARMA INC29668H104COM195,496$733,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333XAD0DBCV 2.250% 6/1600,000$717,000thousands by filing dateprincipal
DICERNA PHARMACEUTICALS INC253031108COM119,300$701,000thousands by filing date
CONCERT PHARMACEUTICALS INC206022105COM66,968$677,000thousands by filing date
COGENTIX MED INC COM19243A104Stock353,482$643,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR30,750$618,000thousands by filing date
SYNERON MEDICAL LTDM87245102ORD85,947$615,000thousands by filing date
MASIMO CORP COM574795100Stock10,000$595,000thousands by filing date
INNOCOLL HLDGS PLCG4783X105SHS100,000$581,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock69,300$468,000thousands by filing date
MINERVA NEUROSCIENCES INC COM NEW603380106Stock33,100$467,000thousands by filing date
PIERIS PHARMACEUTICALS INC720795103COM223,325$408,000thousands by filing date
BLUEBIRD BIO INC09609G100COM6,000$407,000thousands by filing date
IMMUNE DESIGN CORP.45252L103Common Stock40,000$303,000thousands by filing date
CELYAD ONCOLOGY SA151205200ADR12,528$296,000thousands by filing date
AQUINOX PHARMACEUTICALS INC03842B101COM20,000$267,000thousands by filing date
NEURODERM LTDM74231107ORD SHS14,421$267,000thousands by filing date
DEXTERA SURGICAL INC COM252366109CS140,275$264,000thousands by filing date
NEOS THERAPEUTICS INC64052L106COM38,873$256,000thousands by filing date
PALATIN TECHNOLOGIES INC696077403COM PAR $ .01257,193$162,000thousands by filing date
AVINGER INC053734109COM30,800$147,000thousands by filing date
NIVALIS THERAPEUTICS INC65481J109COM15,000$122,000thousands by filing date
CATALYST14888D109COM70,903$86,000thousands by filing date
GENVEC INC NEW37246C307cs95,800$45,000thousands by filing date
CEL SCI CORP150837508COM PAR $0.01127,482$39,000thousands by filing date
CHECK CAP LTDM2361E120*W EXP 02/28/20251,218$29,000thousands by filing date
ENTEROMEDICS INC29365M307COM PAR 0.0133,334$5,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001389933-16-000037this filing2016-11-14acceptance time not in the bulk data set